Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients-Reference-Cited by-同舟云学术

Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients

Published:2021-08-28 Issue:11 Volume:100 Page:2669-2676
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Chenou Francine,Hounkpe Bidossessi Wilfried,Domingos Igor de Farias,Tonassé Wouitchékpo Vincent,Batista Thais Helena Chaves,Santana Rodrigo Marcionilo,Arcanjo Gabriela da Silva,Alagbe Adekunle Emmanuel,Araújo Aderson da Silva,Lucena-Araújo Antonio Roberto,Bezerra Marcos Andre Cavalcanti,Costa Fernando Ferreira,Sonati Maria de Fátima,De Paula Erich Vinicius,dos Santos Magnun Nueldo Nunes^ORCID

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-021-04636-3.pdf

Reference30 articles.

1. Kato GJ, Hebbel RP, Steinberg MH, Gladwin MT (2009) Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine and new research directions. Am J Hematol 84:618–625. https://doi.org/10.1002/ajh.21475

2. Chen J, Hobbs WE, Le J et al (2011) The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma. Blood 117:3680–3684. https://doi.org/10.1182/blood-2010-08-302539

3. Langlois MR, Delanghe JR (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42:1589–1600